Aetna Scraps Obamacare Business Expansion Plans
Aetna said it intended to withdraw plans to expand its Obamacare business next year, and the U.S. health insurer announced the sale of some Medicare Advantage assets to get antitrust nod for its takeover of Humana.
Pfizer's 2Q Profit Tops Expectations
Pfizer reported better-than-expected quarterly revenue and profit, driven by sales of newer drugs and the acquisition of hospital products company Hospira.
Pfizer's 2Q Profit Tops Expectations
Pfizer reported better-than-expected quarterly revenue and profit, driven by sales of newer drugs and the acquisition of hospital products company Hospira.
CVS's Profit Beats Estimates on Pharma Business
CVS Health, the No. 2 U.S. drugstore chain by store count, reported better-than-expected profit helped by strong demand for its pharmacy benefit management (PBM) services.
CVS's Profit Beats Estimates on Pharma Business
CVS Health, the No. 2 U.S. drugstore chain by store count, reported better-than-expected profit helped by strong demand for its pharmacy benefit management (PBM) services.
CVS's Profit Beats Estimates on Pharma Business
CVS Health, the No. 2 U.S. drugstore chain by store count, reported better-than-expected profit helped by strong demand for its pharmacy benefit management (PBM) services.
Procter & Gamble's 4Q Results Beat Estimates
Procter & Gamble, the maker of Tide detergent and Gillette shaving products, reported better-than-expected quarterly sales, helped by strong demand for its baby, feminine and home care products.
Procter & Gamble's 4Q Results Beat Estimates
Procter & Gamble, the maker of Tide detergent and Gillette shaving products, reported better-than-expected quarterly sales, helped by strong demand for its baby, feminine and home care products.
Psst...Your Company's Wireless Costs Are Rising
Twenty or thirty years ago, wireless charges didn’t even exist. But today, wireless and internet charges have become a significant line item on our income statements. You can keep these costs under control, as long as you’re willing to give them the attention they deserve.
Tech Stocks Power Wall St Recovery, S&P Hits New High
Wall Street turned positive in afternoon trading on Friday, with the S&P 500 index hitting a record intraday high for the seventh time this month, as gains in Alphabet and Amazon more than made up for losses in energy shares.
Tech Stocks Power Wall St Recovery, S&P Hits New High
Wall Street turned positive in afternoon trading on Friday, with the S&P 500 index hitting a record intraday high for the seventh time this month, as gains in Alphabet and Amazon more than made up for losses in energy shares.
Chevron Reports 2Q Loss
Dow component Chevron reported a 2Q loss of $0.78 per share. Wall Street was expecting a profit of $0.32. Revenue for the company came in at $29.28 billion, topping the estimate for $28.54 billion
Chevron Reports 2Q Loss
Dow component Chevron reported a 2Q loss of $0.78 per share. Wall Street was expecting a profit of $0.32. Revenue for the company came in at $29.28 billion, topping the estimate for $28.54 billion
Exxon Mobil Profit Tumbles 59% in 2Q, Stock Slides
Exxon Mobil, the world's largest publicly traded oil producer, said on Friday its quarterly profit tumbled 59 percent due to the slump in crude prices.
Exxon Mobil Profit Tumbles 59% in 2Q, Stock Slides
Exxon Mobil, the world's largest publicly traded oil producer, said on Friday its quarterly profit tumbled 59 percent due to the slump in crude prices.
UPS 2Q Profit Climbs on Revenue Growth, Cost Cuts
United Parcel Service reported a higher quarterly net profit on Friday as revenue grew across all its business units and the company benefited from cost-cutting measures.
UPS 2Q Profit Climbs on Revenue Growth, Cost Cuts
United Parcel Service reported a higher quarterly net profit on Friday as revenue grew across all its business units and the company benefited from cost-cutting measures.
Merck Posts Better-Than-Expected Profit, Revenue
Merck & Co reported better-than-expected quarterly profit and revenue, helped by growing demand for its new cancer treatment, Keytruda.
Merck Posts Better-Than-Expected Profit, Revenue
Merck & Co reported better-than-expected quarterly profit and revenue, helped by growing demand for its new cancer treatment, Keytruda.
Merck Posts Better-Than-Expected Profit, Revenue
Merck & Co reported better-than-expected quarterly profit and revenue, helped by growing demand for its new cancer treatment, Keytruda.










